Freenome Gains FDA Breakthrough Device Designation
Brisbane, California, August 12, 2026 Freenome, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...
non-small cell lung cancer
Advertisement
Taiho Oncology Advances Zipalertinib in Phase 3 Trial
Princeton, New Jersey, Tokyo, Japan & Cambridge, Massachusetts, August 12, 2026 Taiho Oncology, Taiho Pharmaceutical, and Cullinan Therapeutics announced...
ImmunityBio Receives UAE Marketing Authorization for ANKTIVA
CULVER CITY, Calif., July 29, 2026 ImmunityBio announced that the Emirates Drug Establishment (EDE) has granted Marketing Authorization for...
Verastem Oncology Doses First Patient in Phase 2 VS-7375 NSCLC Trial
BOSTON, July 22, 2026 Verastem Oncology has announced that the first patient has been dosed in the TARGET-D 202...
Xodus Medical Study Validates Hot Pink Pad Performance
PITTSBURGH, Pa., July 23, 2026 Xodus Medical has announced encouraging results from a new observational clinical study demonstrating that...
Advertisements
GSK Wins FDA Approval for Jideytro in ROS1+ Lung Cancer
LONDON, United Kingdom, July 23, 2026 GSK plc has announced that the U.S. Food and Drug Administration (FDA) has...
City of Hope Launches Phase 2 Lung Cancer Biomarker Trial
LOS ANGELES, July 21, 2026 City of Hope has launched the national Phase 2 IMMUNO-BIOMAP clinical trial to better...
Akeso Starts Phase II Trial of AK146D1 for Advanced NSCLC
HONG KONG, July 20, 2026 Akeso, Inc. has announced a significant milestone in its oncology pipeline with the first...
Kairos Announces Positive Interim Phase 1 ENV-105 Data
LOS ANGELES, July 15, 2026 Kairos Pharma announced encouraging interim safety results from its ongoing Phase 1 clinical trial...
Kelun-Biotech Reports Phase III Success for sac-TMT in NSCLC
CHENGDU, China, July 14, 2026 Kelun-Biotech has announced a major clinical milestone after its Phase III OptiTROP-Lung06 trial evaluating...
Advertisement
